Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX1 | P07099 | 2/20 | 0.61 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.44 |
| ▸ | FAAH | O00519 | 1/20 | 0.41 |
| ▸ | MGLL | Q99685 | 1/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.40 |
| ▸ | CA12 | O43570 | 1/20 | 0.40 |
| ▸ | CA1 | P00915 | 1/20 | 0.40 |
| ▸ | CA2 | P00918 | 1/20 | 0.40 |
| ▸ | CA9 | Q16790 | 1/20 | 0.40 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.40 |
| ▸ | HDAC2 | Q92769 | 2/20 | 0.40 |
| ▸ | MEN1 | O00255 | 2/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8944817 | 1.00 | EPHX1 (0.61) | EPHX1SMN1; SMN2ALDH1A1ALOX15TSHR | |
| Hydrochloric Acid SCHEMBL27795059 | 0.98 | EPHX1 (0.59) | EPHX1SMN1; SMN2ALDH1A1ALOX15TSHR | |
| SCHEMBL8944751 | 0.98 | EPHX1 (0.57) | EPHX1SMN1; SMN2ALDH1A1ALOX15TSHR | |
| SCHEMBL1133959 | 0.93 | — | — | |
| SCHEMBL15610128 | 0.88 | — | — | |
| SCHEMBL27762919 | 0.82 | EPHX1 (0.41) | EPHX1SMN1; SMN2ALDH1A1CYP3A4MAPT | |
| SCHEMBL3068442 | 0.81 | EPHX1 (0.65) | EPHX1SMN1; SMN2ALDH1A1ALOX15TSHR | |
| SCHEMBL10580873 | 0.80 | EPHX1 (0.59) | EPHX1SMN1; SMN2ALDH1A1ALOX15TSHR | |
| SCHEMBL28303600 | 0.80 | EPHX1 (0.39) | EPHX1SMN1; SMN2ALDH1A1ALOX15TSHR | |
| SCHEMBL11509217 | 0.79 | EPHX1 (0.63) | EPHX1SMN1; SMN2ALDH1A1ALOX15TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10821100-B2 | Triazolone compounds as mPGES-1 inhibitors | Ichnos Sciences SA (CH) | 2020-11-03 | — | — | US | disclosed |
| US-20190282548-A1 | TRIAZOLONE COMPOUNDS AS MPGES-1 INHIBITORS | Ichnos Sciences SA (CH) | 2019-09-19 | — | — | US | disclosed |
| US-10391083-B2 | Triazolone compounds as MPGES-1 inhibitors | GLENMARK PHARMACEUTICALS S.A (CH) | 2019-08-27 | — | — | US | disclosed |
| US-20180200229-A1 | TRIAZOLONE COMPOUNDS AS MPGES-1 INHIBITORS | Ichnos Sciences SA (CH) | 2018-07-19 | — | — | US | disclosed |
| US-9949955-B2 | Triazolone compounds as mPGES-1 inhibitors | GLENMARK PHARMACEUTICALS S.A. (CH) | 2018-04-24 | — | — | US | disclosed |
| CN-107011344-A | Method and composition for studying, being imaged and treating pain | 里兰斯坦福初级大学理事会 | 2017-08-04 | — | — | CN | disclosed |
| US-20160339000-A1 | TRIAZOLONE COMPOUNDS AS mPGES-1 INHIBITORS | Ichnos Sciences SA (CH) | 2016-11-24 | — | — | US | disclosed |
| US-9439890-B2 | Triazolone compounds as mPGES-1 inhibitors | GLENMARK PHARMACEUTICALS S.A. (CH) | 2016-09-13 | — | — | US | disclosed |
| EP-2718284-B1 | TRIAZOLONE COMPOUNDS AS mPGES-1 INHIBITORS | GLENMARK PHARMACEUTICALS SA (CH) | 2015-11-18 | — | — | EP | disclosed |
| US-20150283117-A1 | TRIAZOLONE COMPOUNDS AS mPGES-1 INHIBITORS | Ichnos Sciences SA (CH) | 2015-10-08 | — | — | US | disclosed |
| US-5352719-A | Blended with synthetic or natural polymers | ELF ATOCHEM NORTH AMERICA, INC. (US) | 1994-10-04 | — | — | US | disclosed |
| US-5319090-A | Benzotriazole and oxanilide UV absorber hydrazides | ELF ATOCHEM NORTH AMERICA, INC. (US) | 1994-06-07 | — | — | US | disclosed |
| US-5233047-A | Benzotriazole UV absorber hydrazides | ELF ATOCHEM NORTH AMERICA, INC. (US) | 1993-08-03 | — | — | US | disclosed |
| US-5116976-A | HINDERED AMINE LIGHT STABILIZER HYDRAZIDES | ATOCHEM NORTH AMERICA, INC (US) | 1992-05-26 | — | — | US | disclosed |
| EP-0467344-A1 | Hindered amine light stabilizer hydrazides | ELF ATOCHEM NORTH AMERICA, INC. (US) | 1992-01-22 | — | — | EP | disclosed |
| EP-0409840-A4 | BENZOTRIAZOLE AND OXANILIDE UV ABSORBER HYDRAZIDES | — | 1991-09-04 | — | — | EP | disclosed |
| US-5041545-A | 2-hydroxybenzophenone hydrazides and derivatives thereof | ATOCHEM NORTH AMERICA, INC. (US) | 1991-08-20 | — | — | US | disclosed |
| EP-0409840-A1 | BENZOTRIAZOLE AND OXANILIDE UV ABSORBER HYDRAZIDES | ELF ATOCHEM NORTH AMERICA, INC. (US) | 1991-01-30 | — | — | EP | disclosed |
| US-4980420-A | Benzotriazole and oxanilide UV absorber hydrazides | ATOCHEM NORTH AMERICA, INC. (US) | 1990-12-25 | — | — | US | disclosed |
| WO-1990009369-A1 | BENZOTRIAZOLE AND OXANILIDE UV ABSORBER HYDRAZIDES | ATOCHEM NORTH AMERICA, INC. (US) | 1990-08-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150283117-A1 | TRIAZOLONE COMPOUNDS AS mPGES-1 INHIBITORS | PTGES, PTGIS, PTGS1 | EPHX1 135/4885SMN1; SMN2 1893/4885ALDH1A1 157/4885 |
| US-20190282548-A1 | TRIAZOLONE COMPOUNDS AS MPGES-1 INHIBITORS | PTGES, PTGS1, PTGIS | EPHX1 157/4885SMN1; SMN2 1312/4885ALDH1A1 170/4885 |
| US-20160339000-A1 | TRIAZOLONE COMPOUNDS AS mPGES-1 INHIBITORS | PTGES, PTGS1, PTGIS | EPHX1 157/4885SMN1; SMN2 1312/4885ALDH1A1 170/4885 |
| US-10391083-B2 | Triazolone compounds as MPGES-1 inhibitors | PTGES, PTGS1, PTGIS | EPHX1 157/4885SMN1; SMN2 1312/4885ALDH1A1 170/4885 |
| US-20180200229-A1 | TRIAZOLONE COMPOUNDS AS MPGES-1 INHIBITORS | PTGES, PTGS1, PTGIS | EPHX1 157/4885SMN1; SMN2 1312/4885ALDH1A1 170/4885 |
| US-10821100-B2 | Triazolone compounds as mPGES-1 inhibitors | PTGES, PTGS1, PTGIS | EPHX1 157/4885SMN1; SMN2 1312/4885ALDH1A1 170/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.